*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Another step forward in the battle between Illumina and the Commission. The latter announcedon October 29, 2021, that it had adopted, after hearing the parties, interim measures to offset the effects of the anticipated acquisition of Grail by Illumina. It will be recalled that on August 18, 2021, the American company Illumina publicly confirmed that it was planning to
ALERTS: MERGERS – EUROPEAN UNION – NOTIONS – NOTIFICATION – INQUIRIES - INTERIM MEASURES – PHARMACEUTICAL INDUSTRY
Interim measures: The European Commission adopts interim measures to neutralize a possible early acquisition (Grail / Illumina)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.